The IGF/IGF1R axis is involved in the regulation of human growth. Both IGF1 and IGF2 can bind to the IGF1R in order to promote growth via the downstream PI3K/AKT pathway. Pathogenic mutations in IGF1 and IGF1R determine intrauterine growth restriction and affect postnatal body growth. However, to date, there are only few reports of pathogenic IGF2 mutations causing severe prenatal, as well as postnatal growth retardation.
Here we describe a de novo c.195delC IGF2 variant (NM_000612, p.(Ile66Serfs*93)) in a 4-year-old patient with severe pre- and post-natal growth retardation in combination with dystrophy, facial dimorphism, finger deformities, as well as a patent ductus. Cloning and sequencing of a long-range PCR product harboring the deletion and a SNP informative site chr11:2153634 (rs680, NC_000011.9:g.2153634T>C) demonstrated that the variant resided on the paternal allele. This finding is consistent with the known maternal imprinting of IGF2. 3D protein structure prediction and overexpression studies demonstrated that the p.(Ile66Serfs*93) IGF2 gene variation resulted in an altered protein structure that impaired ligand/receptor binding and thus prevents IGF1R activation.
The severity of the phenotype in combination with the dominant mode of transmission provides further evidence for the involvement of IGF2 in growth disorders.
LeRoithDYakarS.Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nature Clinical Practice Endocrinology and Metabolism20073302–310. (https://doi.org/10.1038/ncpendmebib427)
BaxterRC.Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. American Journal of Physiology: Endocrinology and Metabolism2000278E967–E976. (https://doi.org/10.1152/ajpendo.2000.278.6.E967)
EngströmWShokraiAOtteKGranérusMGessboABierkePMadejASjölundMWardA.Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Proliferation199831173–189. (https://doi.org/10.1111/j.1365-2184.1998.tb01196.x)
DemarsJGicquelC.Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes. Clinical Genetics201281350–361. (https://doi.org/10.1111/j.1399-0004.2011.01822.x)
GicquelCRossignolSCabrolSHouangMSteunouVBarbuVDantonFThibaudNLe MerrerMBurglenLEpimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nature Genetics2005371003–1007. (https://doi.org/10.1038/ng1629)
BegemannMZirnBSantenGWirthgenESoellnerLBüttelHMSchweizerRvan WorkumWBinderGEggermannT. Paternally inherited IGF2 mutation and growth restriction. New England Journal of Medicine2015373349–356. (https://doi.org/10.1056/NEJMoa1415227)
Abi HabibWBrioudeFEdouardTBennettJTLienhardt-RoussieATixierFSalemJYuenTAzziSLe BoucYGenetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction. Genetics in Medicine201820250–258. (https://doi.org/10.1038/gim.2017.105)
YamotoKSaitsuHNakagawaNNakajimaHHasegawaTFujisawaYKagamiMFukamiMOgataT. De novo IGF2 mutation on the paternal allele in a patient with Silver-Russell syndrome and ectrodactyly. Human Mutation201738953–958. (https://doi.org/10.1002/humu.23253)
MelchersPPreussU.Revision of the Kaufman assessment battery for children for German speaking regions. Part 2: areas of application and criteria of reliability. Zeitschrift fur Kinder- und Jugendpsychiatrie199220223–231.
BlumWFRankeMBBierichJR.A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinologica1988118374–380. (https://doi.org/10.1530/acta.0.1180374)
DransfieldDTCohenEHChangQSparrowLGBentleyJDDolezalOXiaoXPeatTSNewmanJPillingPAA human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. Molecular Cancer Therapeutics201091809–1819. (https://doi.org/10.1158/1535-7163.MCT-09-1134)
WakelingELBrioudeFLokulo-SodipeOO’ConnellSMSalemJBliekJCantonAPMChrzanowskaKHDaviesJHDiasRPDiagnosis and management of Silver-Russell syndrome: first international consensus statement. Nature Reviews Endocrinology201713105–124. (https://doi.org/10.1038/nrendo.2016.138)
Pagter-Holthuizen PdeHöppenerJWJansenMGeurts van KesselAHvan OmmenGJSussenbachJS. Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. Human Genetics198569170–173. (https://doi.org/10.1007/BF00293291)
VashisthHAbramsCF.All-atom structural models for complexes of insulin-like growth factors IGF1 and IGF2 with their cognate receptor. Journal of Molecular Biology2010400645–658. (https://doi.org/10.1016/j.jmb.2010.05.025)
Powell-BraxtonLHollingsheadPWarburtonCDowdMPitts-MeekSDaltonDGillettNStewartTA.IGF-I is required for normal embryonic growth in mice. Genes and Development199372609–2617. (https://doi.org/10.1101/gad.7.12b.2609)
NetchineIAzziSLe BoucYSavageMO.IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Practice and Research Clinical Endocrinology and Metabolism201125181–190. (https://doi.org/10.1016/j.beem.2010.08.005)
DeChiaraTMEfstratiadisARobertsenEJ.A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature199034578–80. (https://doi.org/10.1038/345078a0)
VerhaegheJVan BreeRVan HerckELaureysJBouillonRVan AsscheFA. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. American Journal of Obstetrics and Gynecology199316989–97. (https://doi.org/10.1016/0002-9378(93)90137-8)
ConstânciaMHembergerMHughesJDeanWFerguson-SmithAFundeleRStewartFKelseyGFowdenASibleyCPlacental-specific IGF-II is a major modulator of placental and fetal growth. Nature2002417945–948. (https://doi.org/10.1038/nature00819)
QiuQYanXBellMDiJTsangBKGruslinA. Mature IGF-II prevents the formation of ‘big’ IGF-II/IGFBP-2 complex in the human circulation. Growth Hormone and IGF Research201020110–117. (https://doi.org/10.1016/j.ghir.2009.11.001)
DaughadayWHTrivediBBaxterRC. Serum ‘big insulin-like growth factor II’; from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. PNAS1993905823–5827. (https://doi.org/10.1073/pnas.90.12.5823)
AlvinoCLMcNeilKAOngSCDelaineCBookerGWWallaceJCWhittakerJForbesBE.A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. Journal of Biological Chemistry20092847656–7664. (https://doi.org/10.1074/jbc.M808061200)
WuSYangWDe LucaF. Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth. Endocrinology20151562541–2551. (https://doi.org/10.1210/en.2014-1983)
EkströmTJCuiHNyströmARutanenEMOhlssonR.Monoallelic expression of IGF2 at the human fetal/maternal boundary. Molecular Reproduction and Development199541177–183. (https://doi.org/10.1002/mrd.1080410208)